Low-cap utility project backed by Microsoft + Google launches tomorrow!

Solana sees new DEXs appear every week, but most follow the same predictable pattern.
Same AMM structure, same vulnerabilities, same trader frustrations:

• bots front-running every order
• high fees draining profits
• zero protection from rugs
• no long-term value for holders

Biokript Pro is the first project built to break this cycle, combining patented hybrid DEX technology with real utility, real revenue, and backing from two of the largest tech companies in the world: Microsoft and Google Cloud.

Launching as a low-cap utility token, BIOK is entering the market with working technology, actual usage, and demand already forming before launch. This is why many believe the upside potential is not just 10× or 100×, but realistically positioned for a 1000× breakout as volume, listings, and exposure compound.

Why Biokript Pro Is Positioned for Massive Growth

Hybrid Execution Engine (Patent Pending)

Not another AMM clone.
Biokript Pro uses a hybrid execution model that enables faster, cleaner swaps with deep structural protection against rugs and predatory bot behavior.
This single innovation alone places it far ahead of traditional Solana DEX models.

True On-Chain Stop-Loss (First on Solana)

For the first time on Solana, traders can use actual on-chain stop-losses, giving them protection from sudden wipes, flash crashes, and unpredictable volatility.
This is a game-changing feature most DEXs still can’t offer.

Anti-MEV, Anti-Front-Run Architecture

Biokript Pro shields transaction details, making sandwich attacks and bot exploitation dramatically harder.
This gives traders:

• fairer entries
• less slippage
• predictable execution

A major reason why early users are calling it the “CEX-experience DEX.”

Ultra-Low 0.1 percent Fee

While platforms like Axiom and GMGN often charge 1 percent fees, Biokript Pro charges just 0.1 percent, making it up to 10× cheaper and a magnet for high-volume traders.

Lower fees → higher volume → higher revenue → higher BIOK distributions → higher token demand.

50 percent Profit Sharing

Half of all platform fees flow directly to BIOK holders.
This is real revenue from a fully operating platform, not theoretical future income.

Utility + revenue share + low supply = the exact formula that historically supported massive multipliers in previous cycles.

Live and Generating Revenue Before Token Launch

Unlike most launches that begin with an idea, a roadmap, and nothing else, Biokript Pro is already:

• live on Solana
• processing real trades
• generating real volume
• producing real revenue

BIOK enters the market with instant utility, giving it the foundation needed for exponential upside.

Backed by Two Tech Giants

Biokript Pro has secured:

• Microsoft for Startups partnership
• $100,000 in Google Cloud credits

This brings enterprise-grade infrastructure, security, and reliability from day one — something extremely rare for low-cap projects.

The Next Phase: The Explosion Begins

The launch is backed by a coordinated global marketing push, including:

• DexScreener visibility
• Cross-platform aggregator boosts
• Influencer and KOL partnerships
• Community AMAs
• Paid ad campaigns
• Large-scale social amplification

With a low starting valuation, strong fundamentals, and massive visibility on day one, BIOK is entering the market with the same conditions that historically created 1000× opportunities in previous cycles.

Everything now leads to one critical moment:

BIOK launches tomorrow, December 3 (18:00–20:00 UTC)

https://biokript.com